1Jacob S, Rett K, Henriksen EJ. Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta blocking agents? [J]. Am J Hypertens, 1998,11:1258-1265.
2Jacob S, Rett K, Wicklmayr M, et al. Differential effect of chomic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study [plublished erratum ppears in J Hypertens 1996;14:1382] [J]. J Hypertens,1995,14: 489-494.
3Giuliano D, Acampora R, Marfella R, et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin dependent diabetes mellitus and hypertension. A randomized controlled trial [J]. Ann Intern Med, 1997,126:955-959.
4Colagiuri S, Cull CA, Holman RR. Are low fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? UK Prospective Diabetes Study 61 [J]. Diabetes Care, 2002,25:1410-1417.
3Mccormick PA,O'keefe C. Improving prognosis following a first variceal haemorrhage over four decades[J]. Gut, 2001,49(5) :682-685.
4Baflares R, Moitinho E, Piqueras B, et al. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alphal-ad- renergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis[J2. Hepatolo- gy,1999,30(1) 79-83.
5Spiegel B, Gralnek IM. Carvedilol or propranolol for variceal prophylaxis? Unconfidence intervals confound the choices[J2. Evid Based Gastroenterol, 2003, 4 (3) : 107-109.
